Science Explorer Back to mapMap
Discussion
Company · New Haven · United States

Vion Pharmaceuticals (United States)

In research, Vion Pharmaceuticals (United States) stands highest in Health Sciences (#13,587 of 16,688 worldwide) and Medicine (#12,344 of 14,558 worldwide), over all time.

vion.comROR OpenAlex
World rank, all time
#27,603
of 34,923
Rank in United States
#5,770
of 7,310
Research works
333
▼ 57% vs 2018-21
Citations
8.2k
24.6 per fractional work
Top-10% rate
6.1%
all institutions 10.0%
vs its own fields
1.00×
1.00× is exactly expected
Open access
41%
world 40%
International
23%
world 18%
Vion Pharmaceuticals (United States)

What is Vion Pharmaceuticals (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Health SciencesDomain #13,587 of 16,688 7.2%173
MedicineField #12,344 of 14,558 7.1%166

Each strip is that field's whole ranked pool, with the notch where Vion Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Vion Pharmaceuticals (United States) work in?

In 2022-now, 54% of research at Vion Pharmaceuticals (United States) is in Health Sciences, 21% in Life Sciences. Its largest fields are Medicine (49%), Psychology (10%), Biochemistry, Genetics and Molecular Biology (9%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 19 fractional works · 54.3% of its workMedicine: 18 fractional works · 49.5% of its workPsychiatry and Mental health: 6 fractional works · 16.8% of its workNeurology: 3 fractional works · 7.3% of its workCardiology and Cardiovascular Medicine: 2 fractional works · 4.8% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 2.5% of its workHematology: 1 fractional works · 2.2% of its workPhysiology: 1 fractional works · 2.2% of its workOncology: 1 fractional works · 1.8% of its workPharmacology: 1 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.4% of its workInfectious Diseases: 0 fractional works · 1.2% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.9% of its workSurgery: 0 fractional works · 0.9% of its workEmergency Medicine: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.3% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workHealth Professions: 2 fractional works · 4.4% of its workGeneral Health Professions: 1 fractional works · 2.3% of its workPharmacy: 0 fractional works · 1.3% of its workSpeech and Hearing: 0 fractional works · 0.5% of its workComplementary and Manual Therapy: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workNursing: 0 fractional works · 0.3% of its workNutrition and Dietetics: 0 fractional works · 0.3% of its workLife Sciences: 8 fractional works · 21.1% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 8.6% of its workMolecular Biology: 2 fractional works · 5.0% of its workCancer Research: 1 fractional works · 1.5% of its workBiochemistry: 0 fractional works · 0.9% of its workClinical Biochemistry: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workNeuroscience: 3 fractional works · 7.1% of its workCognitive Neuroscience: 1 fractional works · 3.9% of its workCellular and Molecular Neuroscience: 1 fractional works · 3.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.3% of its workToxicology: 1 fractional works · 1.6% of its workPharmacology: 1 fractional works · 1.5% of its workPharmaceutical Science: 0 fractional works · 0.2% of its workImmunology and Microbiology: 0 fractional works · 1.2% of its workImmunology: 0 fractional works · 0.8% of its workVirology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workForestry: 0 fractional works · 0.9% of its workSocial Sciences: 6 fractional works · 17.1% of its workPsychology: 4 fractional works · 10.1% of its workClinical Psychology: 2 fractional works · 5.3% of its workExperimental and Cognitive Psychology: 1 fractional works · 2.7% of its workApplied Psychology: 0 fractional works · 0.9% of its workSocial Psychology: 0 fractional works · 0.7% of its workDevelopmental and Educational Psychology: 0 fractional works · 0.5% of its workSocial Sciences: 1 fractional works · 3.2% of its workSociology and Political Science: 1 fractional works · 1.5% of its workSafety Research: 0 fractional works · 0.9% of its workPublic Administration: 0 fractional works · 0.5% of its workHealth: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 1 fractional works · 2.4% of its workEconomics and Econometrics: 1 fractional works · 2.4% of its workArts and Humanities: 0 fractional works · 0.8% of its workPhilosophy: 0 fractional works · 0.8% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workStrategy and Management: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.3% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workPhysical Sciences: 3 fractional works · 7.6% of its workMathematics: 1 fractional works · 3.5% of its workStatistics and Probability: 1 fractional works · 3.5% of its workComputer Science: 1 fractional works · 2.2% of its workComputational Theory and Mathematics: 1 fractional works · 1.5% of its workArtificial Intelligence: 0 fractional works · 0.3% of its workHuman-Computer Interaction: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 0 fractional works · 1.0% of its workMechanical Engineering: 0 fractional works · 0.6% of its workAerospace Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workEnvironmental Science: 0 fractional works · 0.3% of its workEcology: 0 fractional works · 0.3% of its workALL ITS WORKVionPharmaceuticals…36fractional works, 2022-now
Life Sciences21%Physical Sciences8%Health Sciences54%Social Sciences17%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 19 fields, with their numbers
    1. Medicine1849.5%
    2. Health Professions24.4%
    3. Nursing00.3%
    1. Biochemistry, Genetics and Molecular Biology38.6%
    2. Neuroscience37.1%
    3. Pharmacology, Toxicology and Pharmaceutics13.3%
    4. Immunology and Microbiology01.2%
    5. Agricultural and Biological Sciences00.9%
    1. Psychology410.1%
    2. Social Sciences13.2%
    3. Economics, Econometrics and Finance12.4%
    4. Arts and Humanities00.8%
    5. Business, Management and Accounting00.3%
    6. Decision Sciences00.3%
    1. Mathematics13.5%
    2. Computer Science12.2%
    3. Engineering01.0%
    4. Chemistry00.6%
    5. Environmental Science00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.61× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 1.18× its world share, 0 worksImmunology and Micro…Neuroscience: 4.35× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.38× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.40× its world share, 0 worksChemistryComputer Science: 0.28× its world share, 1 worksComputer ScienceEngineering: 0.07× its world share, 0 worksEngineeringEnvironmental Science: 0.06× its world share, 0 worksEnvironmental ScienceMathematics: 2.98× its world share, 1 worksMathematicsHealth Professions: 1.68× its world share, 2 worksHealth ProfessionsMedicine: 2.57× its world share, 18 worksMedicineNursing: 0.63× its world share, 0 worksNursingArts and Humanities: 0.27× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.10× its world share, 0 worksBusiness, Management…Decision Sciences: 0.32× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.11× its world share, 1 worksEconomics, Econometr…Psychology: 3.30× its world share, 4 worksPsychologySocial Sciences: 0.25× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.4×. Every wedge is a field page.

All 19 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.38×1 works
  2. Neuroscience4.35×2 works
  3. Psychology3.30×4 works
  4. Mathematics2.98×1 works
  5. Medicine2.57×18 works
  6. Health Professions1.68×2 works
  7. Biochemistry, Genetics and Molecular Biology1.61×3 works
  8. Immunology and Microbiology1.18×0 works
  9. Economics, Econometrics and Finance1.11×1 works
  10. Nursing0.63×0 works
  11. Chemistry0.40×0 works
  12. Decision Sciences0.32×0 works
  13. Computer Science0.28×1 works
  14. Arts and Humanities0.27×0 works
  15. Social Sciences0.25×1 works
  16. Agricultural and Biological Sciences0.20×0 works
  17. Business, Management and Accounting0.10×0 works
  18. Engineering0.07×0 works
  19. Environmental Science0.06×0 works

Who are the top researchers at Vion Pharmaceuticals (United States)?

Ranked on the quality score, G. Rhys Williams, Robert Silva and ROBERT S. GOLDMAN lead among researchers whose main affiliation is Vion Pharmaceuticals (United States).

  1. 1 G. Rhys Williams United States · #925,365 worldwide 7.7k citations · 54 works
  2. 2 Robert Silva United States · #974,054 worldwide 2.5k citations · 36 works
  3. 3 ROBERT S. GOLDMAN United States · #1,351,520 worldwide 7.1k citations · 133 works
  4. 4 Joyce Tsai United States · #1,529,305 worldwide 2.6k citations · 41 works
  5. 5 Jane Xu United States · #1,647,134 worldwide 1.4k citations · 39 works
  6. 6 Josephine B. Cucchiaro United States · #1,843,092 worldwide 4.4k citations · 136 works
  7. 7 Vaidyanathan Ganapathy United States · #1,921,441 worldwide 774 citations · 30 works
  8. 8 Li-Mou Zheng United States · #1,928,792 worldwide 1.6k citations · 33 works
  9. 9 Kaushik Sarma United States · #1,980,040 worldwide 1.3k citations · 22 works
  10. 10 Caroline Clairmont United States · #2,041,926 worldwide 1.6k citations · 21 works
All ranked researchers at Vion Pharmaceuticals (United States)

What are the most cited papers from Vion Pharmaceuticals (United States)?

The most cited paper from Vion Pharmaceuticals (United States) is "Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma" (John F. Toso, 2002), with 631 citations. Next come "Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo" (479) and "Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective" (390).

Most cited papers
#PaperReleasedCitations
1 Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma John F. Toso · Journal of Clinical Oncology Open access 2002 631
2 Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo K. Brooks Low, Martina Ittensohn, Trung Bao Le et al. · Nature Biotechnology 1999 479
3 Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective Mohamad Shebley et al. · Clinical Pharmacology & Therapeutics Open access 10 Jan 2018 390
4 Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of Salmonella typhimurium Caroline Clairmont, K. C. Lee, Jeremy Andrew Pike et al. · The Journal of Infectious Diseases Jun 2000 359
5 Lurasidone Monotherapy in the Treatment of Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Study Antony D Loebel, Josephine B. Cucchiaro, Robert Silva et al. · American Journal of Psychiatry 30 Oct 2013 344
All 60 most cited papers, with filters and sorting

Which keywords describe research at Vion Pharmaceuticals (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Metabolic Syndrome, Genetics, Inflammation, Neurobiology, Antipsychotic Drugs, Neurocognitive Deficits, Parkinson's Disease and Prevalence.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 33 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 33 words, with their numbers
  1. Inflammation4▲ 4.8×14 topics
  2. Metabolic Syndrome3▲ 11×7 topics
  3. Genetics3▲ 12×5 topics
  4. Neurobiology3▲ 30×4 topics
  5. Antipsychotic Drugs3▲ 183×1 topic
  6. Neurocognitive Deficits3▲ 183×1 topic
  7. Parkinson's Disease2▲ 26×4 topics
  8. Oxidative Stress2▲ 3.7×4 topics
  9. Depression2▲ 6.7×7 topics
  10. Prevalence2▲ 14×4 topics
  11. Neurological Disorders2▲ 9.1×6 topics
  12. Mitochondrial Dysfunction2▲ 17×2 topics
  13. Diagnostic Criteria2▲ 20×3 topics
  14. Neurodegeneration2▲ 16×2 topics
  15. Cognitive Function2▲ 25×2 topics
  16. Dopaminergic Neurons2▲ 70×1 topic
  17. Neuroimaging2▲ 16×3 topics
  18. a-Synuclein2▲ 86×1 topic
  19. Cancer2▲ 3.2×8 topics
  20. Epidemiology2◆ 1.05×9 topics
  21. Meta-Analysis1▲ 6.8×3 topics
  22. Quality of Life1▲ 2.8×5 topics
  23. Epilepsy1▲ 31×2 topics
  24. Stress1▲ 10×4 topics
  25. Treatment1▲ 3.1×3 topics
  26. Treatment Guidelines1▲ 17×2 topics
  27. Bipolar Spectrum Disorder1▲ 147×1 topic
  28. Suicide Risk1▲ 108×1 topic
  29. Antiepileptic Drugs1▲ 41×2 topics
  30. Social Support1▲ 5.9×5 topics
  31. Biomarkers1▲ 4.1×2 topics
  32. Genetic Variation1▲ 13×2 topics
  33. Mental Health1▲ 2.0×5 topics

Which research topics does Vion Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Schizophrenia research and treatment, Parkinson's Disease Mechanisms and Treatments, Bipolar Disorder and Treatment and Neurotransmitter Receptor Influence on Behavior.

Schizophrenia research a…3Schizophrenia research and treatment: 3 fractional worksParkinson's Disease Mechanisms and Treatments: 2 fractional worksBipolar Disorder and Treatment: 1 fractional worksNeurotransmitter Receptor Influence on Behavior: 1 fractional worksStatistical Methods in Clinical Trials: 1 fractional worksAttention Deficit Hyperactivity Disorder: 1 fractional worksReceptor Mechanisms and Signaling: 1 fractional worksEpilepsy research and treatment: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksNeurological disorders and treatments: 1 fractional works
Psychiatry and Mental healthNeurologyCellular and Molecular NeuroscienceStatistics and Probability2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Schizophrenia research and treatment Psychiatry and Mental health 3 works
  2. 2 Parkinson's Disease Mechanisms and Treatments Neurology 2 works
  3. 3 Bipolar Disorder and Treatment Psychiatry and Mental health 1 works
  4. 4 Neurotransmitter Receptor Influence on Behavior Cellular and Molecular Neuroscience 1 works
  5. 5 Statistical Methods in Clinical Trials Statistics and Probability 1 works
  6. 6 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 1 works
  7. 7 Receptor Mechanisms and Signaling Molecular Biology 1 works
  8. 8 Epilepsy research and treatment Psychiatry and Mental health 1 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  10. 10 Neurological disorders and treatments Neurology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.4%not open58.6%

World: 40% of research is openly available.

with international co-authors23.2%domestic only76.8%

World: 18% is written across borders.

How has Vion Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 57% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vion Pharmaceuticals (United States) as a percentage of every work published that year, 0.000029% in 2024.

still counting0.00050%0.0010%Vion Pharmaceuticals (United States)0.000058% in 202519801990200020102020

Fractional works of Vion Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in New Haven

All research institutions in New Haven

Share Vion Pharmaceuticals (United States)'s ranking

Vion Pharmaceuticals (United States) on Science Explorer

A card with Vion Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Vion Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.